$678.59
1.54 (-0.23%)
Last updated: Apr 16, 2026 00:50
Fundamentals Overview
Northrop Grumman Corporation is in the middle of its 52-week range with moderate valuation, trading relatively flat today.
Valuation moderate
Intrinsic value (DCF)
+73.4% upside vs price
Profitability
Risk (Beta)
0.05 — lower vol
Earnings & growth
BullzEye Analysis
Our composite tilts Buy on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Supporting (Buy):
DCF +73.4% upside vs price · Analyst grade: A- · Sentiment improving (2 upgrades) · 3M vs S&P 500: +7.1%
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Ratings & Grades at a Glance
Overall rating: A-. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 13, Equal Weight: 1, Hold: 3, Market Perform: 2, Neutral: 3, Outperform: 2, Overweight: 4, Positive: 2.
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $1,176.82; current price is $678.59. That’s a +73.4% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | 23.19 |
| DCF value (model) | $1,176.82 (73.4% upside) |
| PEG (TTM) | N/A |
| P/B (TTM) | 5.82 |
| P/S (TTM) | 2.3 |
| P/FCF (TTM) | 29.12 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 1.09 |
| Quick Ratio (TTM) | 0.99 |
| Cash Ratio (TTM) | 0.32 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | 9.97% |
| Gross margin (TTM) | 19.81% |
| Operating margin (TTM) | 10.2% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for NOC.
Analyst Sentiment at a Glance
Stock Grades (Institutions)
| Institution | Action | Previous Grade | New Grade | Date |
|---|---|---|---|---|
| Jefferies | maintain | Hold | Hold | 2026-04-09 |
| Citigroup | maintain | Buy | Buy | 2026-04-02 |
| Jefferies | maintain | Hold | Hold | 2026-02-02 |
| Citigroup | maintain | Buy | Buy | 2026-01-28 |
| B of A Securities | maintain | Buy | Buy | 2026-01-28 |
| BTIG | maintain | Buy | Buy | 2026-01-28 |
| UBS | maintain | Buy | Buy | 2026-01-28 |
| RBC Capital | maintain | Outperform | Outperform | 2026-01-28 |
| UBS | maintain | Buy | Buy | 2026-01-15 |
| Citigroup | maintain | Buy | Buy | 2026-01-13 |
| Truist Securities | downgrade | Buy | Hold | 2026-01-09 |
| Morgan Stanley | maintain | Overweight | Overweight | 2025-12-16 |
| Alembic Global | upgrade | Neutral | Overweight | 2025-12-15 |
| Bernstein | maintain | Market Perform | Market Perform | 2025-10-23 |
| BTIG | maintain | Buy | Buy | 2025-10-22 |
| UBS | maintain | Buy | Buy | 2025-10-22 |
| Susquehanna | maintain | Positive | Positive | 2025-10-22 |
| JP Morgan | maintain | Neutral | Neutral | 2025-10-22 |
| Bernstein | maintain | Market Perform | Market Perform | 2025-10-20 |
| Truist Securities | maintain | Buy | Buy | 2025-10-15 |
| Morgan Stanley | maintain | Overweight | Overweight | 2025-10-15 |
| Deutsche Bank | upgrade | Hold | Buy | 2025-10-08 |
| Barclays | maintain | Equal Weight | Equal Weight | 2025-07-29 |
| Susquehanna | maintain | Positive | Positive | 2025-07-23 |
| Baird | maintain | Neutral | Neutral | 2025-07-23 |
| RBC Capital | maintain | Outperform | Outperform | 2025-07-23 |
| Truist Securities | maintain | Buy | Buy | 2025-07-23 |
| Morgan Stanley | maintain | Overweight | Overweight | 2025-07-23 |
| B of A Securities | maintain | Buy | Buy | 2025-07-23 |
| JP Morgan | maintain | Neutral | Neutral | 2025-07-23 |